QUIT
QUIT clinical trials: ACHIEVE LIFE SCIENCES, INC.
Every trial on ClinicalTrials.gov where ACHIEVE LIFE SCIENCES, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 37
- Trials linked
- 31
- As lead sponsor
- 6
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
QUIT on the catalyst calendar · QUIT registry changes
- Primary completion Nov 17, 2016ActualPhase 3NCT01630733A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerAchieve Life Sciences · Non-Small Cell Lung CancerCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 15, 2026Sponsor estimatePhase 3NCT07392125Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E CigarettesAchieve Life Sciences · Vaping CessationNot yet recruitingQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 28, 2023ActualPhase 2NCT05431387A Study of Cytisinicline for Vaping Cessation in Adult SmokersAchieve Life Sciences · VapingCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 21, 2023ActualPhase 3NCT05206370A Second Study of Cytisinicline for Smoking Cessation in Adult SmokersAchieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 23, 2021ActualPhase 3NCT04576949A Study of Cytisinicline for Smoking Cessation in Adult SmokersAchieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 29, 2025ActualPhase 3NCT06435221Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersAchieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 4, 2023ActualPhase 1NCT05631938Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline DoseAchieve Life Sciences · Renal ImpairmentCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 21, 2023ActualPhase 1NCT05981768Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy...Achieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 23, 2022ActualPhase 1NCT05566288Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy SmokersAchieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 12, 2019ActualPhase 1NCT03848208A Single Dose-escalation Study of Cytisine in Adult SmokersAchieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 23, 2019ActualPhase 2NCT03709823Trial of Cytisine in Adult SmokersAchieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 5, 2018ActualPhase 1/Phase 2NCT03303911A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy SmokersAchieve Life Sciences · Smoking CessationTerminatedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 10, 2018ActualPhase 1NCT03509948A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New FormulationAchieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 26, 2017ActualPhase 1NCT03268343A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of CytisineAchieve Life Sciences · Smoking CessationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2014ActualPhase 3NCT01188187Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerAchieve Life Sciences · Prostate CancerCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2016ActualPhase 3NCT01578655Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate CancerAchieve Life Sciences · Prostate CancerCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2013ActualPhase 1NCT01874561Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac RepolarizationAchieve Life Sciences · Cardiac Conduction and RepolarizationCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2013ActualPhase 1NCT01497470A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug...Achieve Life Sciences · CancerCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2013ActualPhase 3NCT01083615A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men...Achieve Life Sciences · Castrate-Resistant Prostate CancerTerminatedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2014ActualPhase 2NCT01454089A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder CancerAchieve Life Sciences · Urologic NeoplasmsCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2011ActualPhase 1NCT00487786Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder CancerAchieve Life Sciences · NeoplasmsCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2010ActualPhase 2NCT00327340Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPCAchieve Life Sciences · Prostate CancerCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2010ActualPhase 1/Phase 2NCT00138658A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)Achieve Life Sciences · Non-small Cell Lung CancerCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2008ActualPhase 1NCT00385177Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid TumorsAchieve Life Sciences · Breast NeoplasmsCompletedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2007ActualPhase 3NCT00251095Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast CancerAchieve Life Sciences · Breast NeoplasmTerminatedQUITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 12 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner